Cancer-predisposing mutations within the RING domain of BRCA1: loss of ubiquitin protein ligase activity and protection from radiation hypersensitivity

Proceedings of the National Academy of Sciences of the United States of America
H RuffnerI M Verma

Abstract

BRCA1 is a breast and ovarian cancer-specific tumor suppressor that seems to be involved in transcription and DNA repair. Here we report that BRCA1 exhibits a bona fide ubiquitin (Ub) protein ligase (E3) activity, and that cancer-predisposing mutations within the BRCA1 RING domain abolish its Ub ligase activity. Furthermore, these mutants are unable to reverse gamma-radiation hypersensitivity of BRCA1-null human breast cancer cells, HCC1937. Additionally, these mutations within the BRCA1 RING domain are not capable of restoring a G(2) + M checkpoint in HCC1937 cells. These results establish a link between Ub protein ligase activity and gamma-radiation protection function of BRCA1, and provide an explanation for why mutations within the BRCA1 RING domain predispose to cancer. Furthermore, we propose that the analysis of the Ub ligase activity of RING-domain mutations identified in patients may constitute an assay to predict predisposition to cancer.

References

Feb 1, 1991·Archives of Neurology·F DelecluseD Zegers de Beyl
Jul 1, 1996·Nature Genetics·E V KooninP Bork
Aug 22, 1996·Nature·M S Chapman, I M Verma
Nov 26, 1996·Proceedings of the National Academy of Sciences of the United States of America·A N MonteiroH Hanafusa
Jul 8, 1997·Proceedings of the National Academy of Sciences of the United States of America·H Ruffner, I M Verma
Feb 3, 1999·Annual Review of Genetics·N Rahman, M R Stratton
Sep 29, 1999·Proceedings of the National Academy of Sciences of the United States of America·K L LorickA M Weissman
Jan 15, 2000·Molecular Cell·R ScullyD M Livingston
Jan 25, 2000·The Journal of Biological Chemistry·T K MacLachlanW S El-Deiry
Feb 9, 2000·Current Biology : CB·P S Freemont
Dec 2, 2000·Nature·R Scully, D M Livingston
Dec 15, 2000·Current Biology : CB·A Vik, J Rine

❮ Previous
Next ❯

Citations

Sep 28, 2002·Genes, Chromosomes & Cancer·Lavinia Vittoria LottiRenato Mariani-Costantini
Apr 10, 2002·International Journal of Hematology·Toshiyasu Taniguchi, Alan D Dandrea
May 27, 2008·Breast Cancer Research and Treatment·Thomas V O HansenFinn C Nielsen
Jun 23, 2009·Breast Cancer Research and Treatment·Kevin SweetAmanda Ewart Toland
Sep 30, 2010·Breast Cancer Research and Treatment·Apichart AtipairinAdisorn Ratanaphan
Jan 5, 2011·Breast Cancer Research and Treatment·Michal KonecnyZdena Bartosova
Aug 25, 2011·Breast Cancer Research and Treatment·Liying ZhangKenneth Offit
Jun 14, 2005·Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences·N ChalabiD J Bernard-Gallon
Oct 1, 2003·Trends in Endocrinology and Metabolism : TEM·Eliot M RosenItzhak D Goldberg
Dec 10, 2002·Biochemical and Biophysical Research Communications·Arzu AtalayIsik G Yulug
Jan 18, 2003·Experimental Cell Research·Megan Fabbro, Beric R Henderson
Nov 13, 2002·Mutation Research·Larry H Thompson, David Schild
Mar 20, 2002·Biochimie·Ralph Scully, Nadine Puget
Dec 26, 2001·Experimental Hematology·M A SiddiqueA D D'Andrea
Jan 16, 2002·Current Opinion in Genetics & Development·Richard Baer, Thomas Ludwig
Aug 29, 2003·The Journal of Steroid Biochemistry and Molecular Biology·Kuniko HorieSatoshi Inoue
Jan 1, 2003·Seminars in Cancer Biology·Richard C GregoryAlan D D'Andrea
Apr 3, 2002·Trends in Molecular Medicine·Nicola C Levitt, Ian D Hickson
Jan 18, 2003·DNA Repair·Stephen C West
Jan 17, 2009·Chemical Reviews·Katherine WickliffeMichael Rape
Sep 29, 2011·Journal of Proteome Research·Meihua SongYuzuru Shiio
Feb 6, 2004·Breast Cancer Research and Treatment·Marc Lacroix, Guy Leclercq
Sep 28, 2013·Cell Death & Disease·B BenassiG Blandino
Apr 25, 2006·Nature Reviews. Cancer·Irmgard Irminger-Finger, Charles Edward Jefford
Jul 4, 2006·Nature Reviews. Drug Discovery·Grzegorz NalepaJ Wade Harper
Feb 21, 2008·Nature Reviews. Molecular Cell Biology·Dana Branzei, Marco Foiani
Jan 8, 2008·Nature Structural & Molecular Biology·Eric J Bennett, J Wade Harper
Dec 18, 2008·Proceedings of the National Academy of Sciences of the United States of America·Latarsha J ReidThomas Ludwig
Feb 27, 2010·The Journal of Biological Chemistry·Tapas SahaEliot M Rosen
Oct 30, 2013·Annals of Oncology : Official Journal of the European Society for Medical Oncology·B Pothuri
Jul 5, 2006·Genes & Development·Xiaochun YuJunjie Chen

❮ Previous
Next ❯

Related Concepts

Related Feeds

Breast Cancer: BRCA1 & BRCA2

Mutations involving BRCA1, found on chromosome 17, and BRCA2, found on chromosome 13, increase the risk for specific cancers, such as breast cancer. Discover the last research on breast cancer BRCA1 and BRCA2 here.

Allergy and Asthma

Allergy and asthma are inflammatory disorders that are triggered by the activation of an allergen-specific regulatory t cell. These t cells become activated when allergens are recognized by allergen-presenting cells. Here is the latest research on allergy and asthma.

Cell Checkpoints & Regulators

Cell cycle checkpoints are a series of complex checkpoint mechanisms that detect DNA abnormalities and ensure that DNA replication and repair are complete before cell division. They are primarily regulated by cyclins, cyclin-dependent kinases, and the anaphase-promoting complex/cyclosome. Here is the latest research.